Malcolm A Finkelman

Title: The Innovations of Malcolm A. Finkelman in Biocatalysis

Introduction

Malcolm A. Finkelman, based in Gaithersburg, MD, is an inventor recognized for his significant contributions to biocatalysis. With one patent to his name, he has made notable strides in the production of phenylalanine ammonia-lyase (PAL), an enzyme with important applications in biotechnology.

Latest Patents

Finkelman's patent titled "Method for the production of phenylalanine ammonia-lyase by fermentation" reflects his innovative approach to enzyme stability. The method enhances the useful life of PAL by maintaining PAL-containing media in anaerobic, static conditions. This innovative technique is crucial for catalyzing the conversion of t-cinnamic acid and ammonia into L-phenylalanine, which is valuable in various biochemical processes.

Career Highlights

Malcolm A. Finkelman has worked at Genex Corporation, where he has been at the forefront of developing enzymatic methods that streamline production processes in biotechnology. His scientific expertise and innovative mindset contribute to the company's goals of advancing biocatalytic technologies.

Collaborations

Finkelman's work has involved collaboration with his coworker, Huei-Hsuing Yang. Their partnership exemplifies the importance of teamwork in research and innovation, driving forward the boundaries of what is possible in enzyme technology.

Conclusion

Malcolm A. Finkelman's patent reflects a significant advancement in enzyme production methods. His work at Genex Corporation, along with collaborative efforts, underscores the impact of inventors on the field of biotechnology. As the industry continues to evolve, Finkelman's contributions remain crucial for future innovations in biocatalysis.